MUSTANG BIO, INC. Operating Lease Cost
MUSTANG BIO, INC. (MBIO) reported Operating Lease Cost of $20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-19
- MUSTANG BIO, INC. operating lease, cost for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, cost for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, cost for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, cost for the quarter ending 2025-03-31 was $20.00K, a 61.54% decline year-over-year.
- MUSTANG BIO, INC. operating lease, cost for fiscal 2025 was $20.00K, a 86.21% decline from fiscal 2024.
- MUSTANG BIO, INC. operating lease, cost for fiscal 2024 was $145.00K, a 66.97% decline from fiscal 2023.
- MUSTANG BIO, INC. operating lease, cost for fiscal 2023 was $439.00K, a 22.30% decline from fiscal 2022.
- MUSTANG BIO, INC. operating lease, cost for fiscal 2022 was $565.00K, a 79.37% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $0.00 derived: sum of 3 quarters · filed 2026-03-19 | $20.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $20.00K 10-Q · filed 2025-11-07 | $52.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $20.00K 10-Q · filed 2025-08-08 | $52.00K derived: sum of 3 quarters · filed 2026-03-19 | $87.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-03-31 | $20.00K 10-Q · filed 2025-05-14 | $52.00K derived: sum of 2 quarters · filed 2026-03-19 | $87.00K derived: sum of 3 quarters · filed 2026-03-19 | $113.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $67.00K derived: sum of 2 quarters · filed 2026-03-19 | $93.00K derived: sum of 3 quarters · filed 2026-03-19 | $145.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $61.00K derived: sum of 2 quarters · filed 2025-11-07 | $113.00K 10-Q · filed 2025-11-07 | -$40.00K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $78.00K 10-Q · filed 2025-08-08 | -$75.00K derived: sum of 3 quarters · filed 2025-08-08 | $122.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $52.00K 10-Q · filed 2025-05-14 | -$101.00K derived: sum of 2 quarters · filed 2025-05-14 | $96.00K derived: sum of 3 quarters · filed 2025-05-14 | $294.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $44.00K derived: sum of 2 quarters · filed 2025-03-28 | $242.00K derived: sum of 3 quarters · filed 2025-03-28 | $439.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $395.00K derived: sum of 2 quarters · filed 2024-11-08 | $592.00K 10-Q · filed 2024-11-08 | $743.00K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $395.00K 10-Q · filed 2024-08-13 | $546.00K derived: sum of 3 quarters · filed 2024-08-13 | $790.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $197.00K 10-Q · filed 2024-05-15 | $348.00K derived: sum of 2 quarters · filed 2024-05-15 | $592.00K derived: sum of 3 quarters · filed 2024-05-15 | $677.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $395.00K derived: sum of 2 quarters · filed 2024-03-11 | $480.00K derived: sum of 3 quarters · filed 2024-03-11 | $565.00K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $329.00K derived: sum of 2 quarters · filed 2023-11-14 | $414.00K 10-Q · filed 2023-11-14 | $497.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $170.00K 10-Q · filed 2023-08-14 | $253.00K derived: sum of 3 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $85.00K 10-Q · filed 2023-05-12 | $168.00K derived: sum of 2 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $315.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $232.00K 10-Q · filed 2022-11-14 | ||||
| 2021-03-31 | $76.00K 10-Q · filed 2021-05-14 | $152.00K derived: sum of 2 quarters · filed 2022-03-23 | $245.00K derived: sum of 3 quarters · filed 2022-03-23 | $323.00K derived: sum of 4 quarters · filed 2022-03-23 | |
| 2020-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $169.00K derived: sum of 2 quarters · filed 2022-03-23 | $247.00K derived: sum of 3 quarters · filed 2022-03-23 | $330.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $171.00K derived: sum of 2 quarters · filed 2020-11-06 | $254.00K 10-Q · filed 2020-11-06 | $331.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $161.00K 10-Q · filed 2020-08-10 | $238.00K derived: sum of 3 quarters · filed 2021-05-14 | $316.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-03-31 | $83.00K 10-Q · filed 2021-05-14 | $160.00K derived: sum of 2 quarters · filed 2021-05-14 | $238.00K derived: sum of 3 quarters · filed 2021-05-14 | $317.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $155.00K derived: sum of 2 quarters · filed 2021-03-24 | $234.00K derived: sum of 3 quarters · filed 2021-03-24 | $312.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $78.00K 10-Q · filed 2019-11-12 | $157.00K derived: sum of 2 quarters · filed 2020-08-10 | $235.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $157.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $78.00K 10-Q · filed 2020-05-11 | $78.49M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |